Abstract
Thanks to advances in assay techniques and routine measurements in serum chemical analysis, primary hyperparathyroidism has become far more frequently detected, and the number of asymptomatic patients has substantially increased. In the majority of patients (85%), a solitary adenoma is the underlying cause of primary hyperparathyroidism. Surgical excision is the treatment of choice for most cases of primary hyperparathyroidism; this procedure has a relatively high success rate. In the past decade, improvements in preoperative imaging have played a major role in a targeted operative approach, which allows for minimally invasive surgery to be performed. The success of parathyroid surgery depends on the accurate preoperative localization of parathyroid adenoma. In this study, we report the case of a 54 year-old woman with primary hyperparathyroidism who presented with left buttock and leg pain. For localization of the parathyroid lesion, an ultrasonography and a $^{99m}Tc$-sestamibi scan were initially performed, but these attempts failed to localize the lesion. We then carried out contrast-enhanced CT; thereafter, a single parathyroid adenoma was detected. Therefore, in patients with negative results on both ultrasonography and $^{99m}Tc$-sestamibi scan, contrast-enhanced CT may prove helpful for preoperative parathyroid localization.
Introduction
Primary hyperparathyroidism (PHPT) is typically characterized by the autonomous overproduction of parathyroid hormone (PTH), leading to hypercalcemia and associated complications such as bone resorption and nephrolithiasis. While surgical intervention remains the definitive treatment, the clinical paradigm has shifted from traditional bilateral neck exploration toward minimally invasive parathyroidectomy (MIP). The success of MIP is entirely dependent on the precise preoperative localization of the offending adenoma, usually achieved via neck ultrasonography (US) and $^{99m}Tc$-sestamibi scintigraphy.
However, these standard imaging modalities are not infallible. When both US and scintigraphy fail to identify a lesion, clinicians face a diagnostic challenge. This case report highlights the utility of contrast-enhanced Computed Tomography (CT) as a rescue modality and explores the histopathological and genetic factors that may contribute to "imaging-negative" parathyroid adenomas.
Case Presentation
A 54-year-old woman presented with persistent left buttock and leg pain. Laboratory investigations revealed a biochemical profile consistent with PHPT: elevated serum calcium (10.8 mg/dL), decreased phosphorus (2.3 mg/dL), and significantly elevated intact PTH (165.4 pg/mL).
The Localization Challenge
Initial diagnostic efforts focused on localizing the suspected adenoma. Neck ultrasonography failed to identify any suspicious masses. Subsequently, a $^{99m}Tc$-sestamibi scan was performed. Despite the high sensitivity usually associated with this tracer, the scan showed no abnormal focal uptake in the thyroid bed or mediastinum at either the 10-minute or 2-hour marks.
Given the negative results of standard imaging, a contrast-enhanced CT of the neck was performed. The CT successfully identified a 2.5 cm enhancing mass located in the right tracheoesophageal groove, posterior to the right thyroid lobe.
Surgical and Pathological Findings
Guided by the CT findings, the patient underwent a targeted right-sided parathyroidectomy. A 2.5 × 1.5 × 1.0 cm enlarged parathyroid gland was excised from the exact location predicted by the CT. Postoperative biochemical analysis confirmed a cure, with PTH and calcium levels normalizing within 24 hours.
Histopathological examination provided insight into why the $^{99m}Tc$-sestamibi scan may have failed. The scan's efficacy relies on the accumulation of the tracer within mitochondria-rich cells. In this case, the adenoma was composed predominantly of chief cells with a notably low concentration of oxyphil cells (which are mitochondria-dense).
Genetic Analysis
To further investigate the patient's physiology, direct sequencing of the calcium-sensing receptor (CaSR) gene was performed. The analysis identified a heterozygous missense substitution (c.2968T>C), resulting in the R990G polymorphism. While not the primary cause of the adenoma, this variant is associated with increased sensitivity of the CaSR in the kidneys, which can influence the biochemical presentation of PHPT by increasing urinary calcium excretion.
Conclusion
This case demonstrates that while ultrasonography and $^{99m}Tc$-sestamibi scans are the standard of care, they can yield false negatives due to anatomical factors (e.g., deep location in the tracheoesophageal groove) or biological factors (e.g., low oxyphil cell content). Contrast-enhanced CT serves as a highly effective secondary imaging tool in these instances, allowing surgeons to maintain a minimally invasive approach even when traditional scans fail.
Summary updated